Understanding Retatrutide: A Multi-Receptor Approach to Weight Management Retatrutide is an investigational weight loss treatment that has gained attention in clinical research for its potential in managing obesity and supporting overall metabolic health
For Wegovy, the STEP 1 trial found an average of approximately 10% by the same point
Anyiam, A., Ardavani, A., Rashid, M., Panesar, K., & Idris, I
But the same principle applies throughout the body
For similar supplements to support your weight management journey, check out GLP-1 Supplements and Nutrition
Home Metabolic Retatrutide (10mg) Metabolic Research Peptide GLP-1 / GIP / Glucagon triple-receptor agonist Research-grade, Australia In stock dispatched Australia-wide View & buy on store Retatrutide (development code LY3437943) is a synthetic triple-agonist peptide that acts on three metabolic receptor targets at once: the glucagon-like peptide-1 (GLP-1) receptor, the glucose-dependent insulinotropic polypeptide (GIP) receptor, and the glucagon receptor